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Abstract
Deubiquitinating enzymes (DUBs) are important regulators of cell proliferation. Here we identified a functional
deubiquitinating enzyme, ovarian tumor domain-containing 6B (OTUD-6B). Mutation of the conserved Cys residue
abolished its deubiquitinating activity in vitro. Otud-6b expression was induced with cytokine stimulation in both mouse Ba/
F3 cells and primary B lymphocytes followed a rapid decrease. This rapid decrease was partially facilitated by tristetraprolin
(TTP) destabilization of Otud-6b mRNA through AU-rich motifs. Enforced expression of OTUD-6B in Ba/F3 cells could block
cell proliferation by arresting cells in G1 phase. In addition, cyclin D2 level was down-regulated when OTUD-6B WT was
overexpressed. Therefore, down-regulation of Otud-6b expression after prolonged cytokine stimulation may be required for
cell proliferation in B lymphocytes.
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Introduction
The ubiquitin-mediated proteolytic pathway is involved in
multiple cellular processes including cell cycle regulation [1],
transcriptional activation [2], and antigen presentation [3]. In
addition to ubiquitination, the importance of deubiquitinating
enzymes (DUBs) has been demonstrated recently [4,5,6]. DUBs
can either recycle ubiquitin as components of the 26S proteasome
[7] or rescue proteins from the degradation pathway by
deubiquitination [7,8]. There are five sub-families of DUBs
classified by their sequence diversity: the ubiquitin C-terminal
hydrolases (UCHs), the ubiquitin-specific peptidases (USPs/
UBPs), the ovarian tumor (OTU) domain proteins, the Josephin
or Machado-Joseph disease (MJD) proteins, and the JAMM (Jab1/
MPN domain-associated metalloisopeptidase) domain proteins.
The JAMM proteins are zinc metalloisopeptidases, while the other
four families are cysteine peptidases [9].
B cell fate is essentially associated with the adaptive immune
system [10], and B cell fate is modulated by cytokines during its
maturation, homeostasis, and proliferation through target genes
expression [11,12]. Recently, mouse Dub-1, Dub-1a, Dub-2, and
Dub-2a were reported to be hematopoietic-specific DUBs in B
lymphocytes. Their expression levels were rapidly induced upon
cytokine stimulation, which is probably due to the cytokine-
inducible enhancer in the 59-UTR [13,14]. Interestingly, the
expression levels of those DUBs were sharply down-regulated
following the fast induction and little is known about this fast
down-regulation. These four DUBs belong to the USP17 gene
family, members of which form part of highly polymorphic
tandem repeat sequences on mouse chromosome 7 [15]. There is
no other DUB reported to present this induction-decline
expression pattern. More recently, microarray data have shown
that many OTU family members were rapidly up-regulated
or down-regulated in human esophageal epithelial cells and
lymphocytes when stimulated by different cytokines, such as
ovarian tumor domain containing 6B (OTUD-6B), a novel
DUB of the OTU family members. OTUD-6B was originally
named as CGI-77 and has deubiquitinating enzyme activity in vitro
[16]. It was up-regulated on human esophageal epithelial cells
after interleukin-13 (IL-13) stimulation [17]. BAFF, a B cell-
activating factor of the TNF family, could also induce Otud-6b
expression on mouse B cells after 4 hours stimulation [18].
However, granulocyte colony-stimulating factor (G-CSF) could
effectively down-regulate OTUD-6B expression when human
leukocytes were stimulated for 16 hours [19]. Although these
experiments showed that OTU family members were regulated by
cytokines, little is known about the mechanism and function of
such regulations.
Here we report that Otud-6b, a functional DUB of the OTU
family, can be induced by IL-3, IL-4, IL-13 and granulocyte-
macrophage colony-stimulating factor (GM-CSF) stimulation in B
lymphocytes. However, prolonged stimulation with these cytokines
effectively decreased the expression of Otud-6b. This is the first
OTU family member to be reported to have such cytokines
response. To further investigate the down-regulation mechanism,
we knocked down several proteins involved in mRNA regulation
and found that tristetraprolin (TTP) was responsible for Otud-6b
mRNA rapid degradation. Enforced expression of OTUD-6B
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e14514could block cell growth and arrest cells in G1 phase. Apoptosis
assays showed that overexpression of OTUD-6B in Ba/F3 cells
increased the number of cells in subG1 and pro-apoptotic stages.
In addition, cyclin D2 expression level was down-regulated when
OTUD-6B WT was overexpressed in Hela and Ba/F3 cells, while
overexpression of OTUD-6B C188S, which abolished its deubi-
quitinating activity, had no effect on cyclin D2 level. Therefore,
OTUD-6B may participate in cell cycle regulation in B
lymphocytes after cytokine stimulation.
Results
OTUD-6B is a Functional Deubiquitinating Enzyme
Human OTUD-6B, also named as DUBA5 and CGI-77, is
located on Chr8: 92151719-92168498 [20]. Specific primers were
designed to amplify OTUD-6B cDNA from Raji cells by RT-PCR
(Figure 1A). The sequence of OTUD-6B cDNA clone was
identical to GeneBank NM_016023. The full-length OTUD-6B
cDNA is 3306 bp and contains a 972-bp ORF. The mouse
homolog Otud-6b cDNA is 3311 bp long and consists of seven
exons encoding a 325-amino acid mouse Otud-6b protein. The
protein homology between human OTUD-6B and mouse Otud-
6b is about 87% (Figure S1). We analyzed the expression pattern
of Otud-6b mRNA in mouse tissues by RT-PCR using the Otud-
6b specific primers. RT-PCR results revealed that Otud-6b
mRNA is expressed in various mouse tissues, including brain,
heart, lung, kidney, ovary, spleen, and B lymphocytes (Figure 1B),
which indicated that Otud-6b is probably a widely expressed
housekeeping gene.
Next we investigated whether OTUD-6B is a functional
deubiquitinating enzyme. Sequence alignment on human OTU
family members indicated that the Cys188 is the putative conserved
Cys residue in OTUD-6B [21]. Therefore, we mutated this site
into a Ser to generate an OTUD-6B C188S mutant. In vitro
deubiquitinating enzyme assay showed that GST-OTUD-6B WT
fusion protein could deubiquitinate Ub-Met-b-gal to an extent
comparable to GST-CYLD, which is a reported functional DUB
[22,23], while the OTUD-6B C188S mutant failed to cleave the
Ub-Met-b-gal substrate (Figure 1C). Immunoblot confirmed that
all GST fusion proteins were synthesized effectively (Figure S2).
These results demonstrated that OTUD-6B is a functional
deubiquitinating enzyme in vitro.
Cytokines could Induce Otud-6b Expression in B
lymphocytes Followed by a Rapid Decline
As microarray data have showed that OTUD-6B expression
levels could be regulated upon cytokine stimulation [17,18,19,20].
To investigate the response of Otud-6b expression levels to
cytokine stimulation in B lymphocytes, we first examined that in
Ba/F3 cells, a mouse pro-B cell line. The mRNA levels of Otud-6b
Figure 1. OTUD-6B is a functional deubiquitinating enzyme. A. Molecular cloning of the cDNA of human OTUD-6B was amplified from total
RNA of Raji cells and subjected to 1% agarose gel analysis. B. The expression of mouse Otud-6b mRNA in Ba/F3 cells [5], CTLL-2 cells and various
tissues (brain, heart, liver, lung, kidney, ovary, and spleen) was analyzed by RT-PCR using Otud-6b-specific primers. G3PDH was used as control. Ba/F3
cells were kindly supplied by prof. Xin yuan Liu (Shanghai Institute of Biochemistry and Cell Biology, SIBS, CAS). CTLL2 cells were provided by the Cell
Bank, Shanghai Institute of Biochemistry and Cell Biology, SIBS, CAS. C. Ub-Met-b-gal fusion protein was prepared from MC1061 cells. The
supernatant was incubated with purified GST (lane 1), OTUD-6B WT (lane 2), OTUD-6B C188S (lane 3), GST (lane 4), GST-CYLD WT (lane 5), and GST-
CYLD CS (lane 6) fusion protein at 4uC with rotation for 4 hours. Both OTUD-6B WT and GST-CYLD WT could cleave ubiquitin from the Ub-Met-b-gal
fusion protein.
doi:10.1371/journal.pone.0014514.g001
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different concentrations of IL-3, IL-4, IL-13, and GM-CSF (0,
0.01, 0.1, 1, 10, 100, and 1000 pM) (Figure 2A). We also tested
the time course response for Otud-6b mRNA expression in Ba/F3
cells under 10 pM IL-3, IL-4, IL-13, or GM-CSF stimulation
(Figure 2B). Our results showed that Otud-6b mRNA expression
levels were increased from 0 to 2 hours but decreased rapidly after
4–6 hours with those cytokines stimulation. On the other hand,
IL-2 could not induce Otud-6b expression in Ba/F3 cells (Figure
S3). A rabbit polyclonal antibody for Otud-6b/OTUD-6B was
developed to facilitate our studies on the endogenous protein
(Figure S4). Then endogenous Otud-6b expression changes were
tested in similar time course experiments with 10 pM mouse IL-3
or IL-4. Immunoblot results showed that endogenous Otud-6b
protein was induced after 1 hour IL-3 stimulation and declined
after 4 hours (Figure 2C), while the response with IL-4
stimulation was slower as endogenous Otud-6b protein expression
could only be detected after 4 hours and declined after 6 hours of
stimulation (Figure 2D). Such difference on mRNA kinetics
between IL-3 and IL-4 stimulation is probably due to different
downstream signaling pathways induced by those two cytokines
[24].
To confirm the induction effect of Otud-6b in B lymphocytes,
we next conducted similar experiments in primary B cells from
C57BL/6 mice. Similar time course and concentration course
experiments were performed on those primary B cells with IL-3
stimulation. The time course experiments showed that both Otud-
6b mRNA and protein were induced after 1 hours’ stimulation
and declined after 3 hours’ stimulation (Figure 2E&F). The
concentration course experiments showed that the induced Otud-
6b mRNA and protein could be detected with 0.1 pM or higher
IL-3 stimulation for 2 hours (Figure 2G&H). Therefore, Otud-6b
could also be induced in mouse primary B cells with IL-3
stimulation. Although this cytokine stimulation pattern has been
reported for Dub-1 and Dub-2a, Otud-6b is the first OTU family
member found to be regulated by cytokines in B lymphocytes.
OTUD-6B Overexpression Slows Proliferation and
Increases the Rate of Apoptosis
During our cytokine stimulation experiments, we observed an
interesting rapid down-regulation of Otud-6b after prolonged
cytokine stimulation. We wanted to understand why Otud-6b is so
rapidly down-regulated after prolonged stimulation. Therefore, we
enforced OTUD-6B expression in Ba/F3 cells to overturn the
down-regulation. Interestingly, overexpression of OTUD-6B
could affect cell proliferation and cell cycle in Ba/F3 cells. While
cells transfected with pcDNA3.1(+)and OTUD-6B C188S mutant
vector doubled 2-3 times after 48 hours of culture, OTUD-6B WT
vector transfected cells showed a substantial reduction in the
proliferation rate (Figure 3A). PI staining was also performed on
those cells. There were only about 28% OTUD-6B WT
transfected cells in S and G2/M phase while there were 47%
control cells and 46% OTUD-6B C188S transfected cells in those
phases (Figure 3B). Therefore, there were more OTUD-6B WT
transfected cells arrested in G1 phase (72% versus 53% in control
and 54% in OTUD-6B C188S transfected cells, Figure 3B).
Moreover, PI-Annexin V assays were also performed on Ba/F3
cells 32 hours after transfection. The ratio of PI
(2)/AnnexinV
(+)
cells in OTUD-6B WT expressing cells was 16.5%62.5%
(p,0.03), which was significantly higher than that of pcDNA3.1(+)
vector and OTUD-6B C188S transfected cells (Figure 3C) even
though the expression levels of wild-type and mutant OTUD-6B
were similar (Figure 3D). These findings indicated that
overexpression of OTUD-6B WT in Ba/F3 cells can block cell
proliferation and lead to apoptosis, while down-regulation of
Otud-6b in Ba/F3 cells has no such effect (Figure S5).
Cyclin D2 was Down-regulated when OTUD-6B was
Overexpressed
Next we checked the cell cycle regulator(s) in OTUD-6B
expressing cells. Real-time PCR of the cell cycle regulators was
performed on the RNAs from Tet-On advanced HA-OTUD-6B
Hela cells with or without DOX induction. OTUD-6B mRNA
level in DOX(+) cells was about 7 times higher than that in
DOX(2) cells and cyclin D2, a G1/S cell cycle regulator, was
down-regulated about 70% in DOX(+) cells compared to
DOX(2) cells (Figure 4A). There is no significant difference on
the mRNA levels of the other regulators (cyclin D1, cyclin D3,
p21, p27, p15, p16, cdk4, cdk6, cdc2, cyclin E, Rb, and c-Myc
genes). We also confirmed this down-regulation of cyclin D2
through RT-PCR and immunoblot (Figure 4B & Figure 4C).
Moreover, down-regulation of cyclin D2 was correlated with
increased HA-OTUD-6B WT expression (Figure 4D &
Figure 4E). OTUD-6B C188S had no effect on cyclin D2
(Figure 4F). Similar results were also obtained in Ba/F3 cells
(Figure 4G). Over all, these data indicated that cyclin D2 level is
down-regulated in OTUD-6B overexpressing cells and such down-
regulation is dependent on OTUD-6B’s catalytic activity even
though we did not observe any deubiquitinating activity of
OTUD-6B on cyclin D2 (data not shown). Down-regulation of
OTUD-6B also has no effect on cyclin D2 level in those cells
(Figure S6).
TTP Destabilizes Otud-6b mRNA through its 39UTR
Otud-6b mRNA was rapidly down-regulated after prolonged
cytokine induction. In order to investigate the mechanism of such
rapid decay, we investigated several possible regulation pathways
for mRNA degradation. MicroRNAs are reported to be involved
in directing mRNA degradation of the target genes [25]. Down-
regulation of Dicer1, which is essential in processing small RNAs,
had no effect on Otud-6b mRNA level (Figure S7). This data
indicated that microRNAs probably do not regulate Otud-6b
mRNA stability under our conditions. Several RNA binding
proteins including TTP, AU-rich element RNA-binding protein 1
(AUF1), and butyrate response factor-1 (BRF1) have been shown
to be able to regulate ARE-mRNAs stability [26,27,28].
Therefore, we analyzed Otud-6b mRNA sequence and found
that there are several AU-rich sequence motifs in the 39UTR of
mouse Otud-6b (Figure 5A). We then checked Otud-6b mRNA
levels in Ba/F3 cells when TTP, AUF1, and BRF1 were knocked
down respectively. While there was no effect in Otud-6b mRNA
levels with AUF1 and BRF1 knock-down (Figure S7), the
degradation of Otud-6b mRNA was delayed when TTP was
effectively down-regulated by pSUPER siTTP-1 and siTTP-2
(Figure 5B & Figure 5C). Both scramble siRNA and mock
vector control had no effect on Otud-6b mRNA degradation rate
(Figure S8). To quantitatively determine the effect of TTP on
endogenous Otud-6b mRNA stability, actinomycin D (a tran-
scription inhibitor) chase were performed on Ba/F3 cells treated
with IL-3 for 3 hours. The stability of Otud-6b mRNA was
significantly increased when TTP was knocked down
(t1/2=2.260.2 h (p,0.01) for Mock versus t1/2=5.660.3 h
(p,0.02) for siRNA-1 and t1/2=4.960.3 h (p,0.02) for siRNA-
2, Figure 5D). Semi-quantitative RT-PCR analysis confirmed
that Otud-6b mRNA was more stable after TTP knockdown
(Figure 5E). These data suggest that TTP controls the decay rate
of Otud-6b mRNA in response to IL-3 stimulation.
OTUD-6B in Cell Proliferation
PLoS ONE | www.plosone.org 3 January 2011 | Volume 6 | Issue 1 | e14514Figure 2. Otud-6b expression is induced by cytokines following by a rapid decline. A. Otud-6b RNA level in Ba/F3 cells after starvation and
two hours stimulation with different concentrations (0, 0.01, 0.1, 1, 10, 100, and 1000 pM) of mouse IL-3, IL-4, IL-13, and GM-CSF. B. Otud-6b RNA level
in Ba/F3 cells after starvation and stimulation with 10 pM mouse IL-3, IL-4, IL-13, and GM-CSF for the indicated times (0, 0.5, 1, 2, 4, 8, and 16 hours).
C&D. Ba/F3 cells were starved and stimulated with 10 pM mouse IL-3 or IL-4 for the indicated time. Otud-6b expression of the Ba/F3 cell lysates was
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PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e14514In order to confirm TTP could regulate Otud-6b mRNA, we
investigated the specifity and interaction of TTP with Otud-6b
mRNA in Ba/F3 cells. We first performed protein-mRNA
complex immunoprecipitation assay on HA-TTP expressing Ba/
F3 cells. Otud-6b mRNA could be detected by RT-PCR from
TTP-RNA complex immunoprecipitated with anti-HA antibody
Figure 3. OTUD-6B overexpression slows proliferation and increases the rate of apoptosis. A. Ba/F3 cells were transfected with
pcDNA3.1(+), OTUD-6B WT, and OTUD-6B C188S vectors. Thirty-two hours later, Ba/F3 cells were seeded at 2610
5 cells per ml and analyzed at
16-hour intervals by trypan blue staining. B. Ba/F3 cells were transfected with pcDNA3.1(+), OTUD-6B WT, and OTUD-6B C188S vectors. Thirty-two
hours later, cells were stained using PI and analyzed by flow cytometry. Cell cycle profile from three independent experiments was calculated
statistically. C. PI-Annexin V analysis among pcDNA3.1(+), OTUD-6B WT, and OTUD-6B C188S-expressing Ba/F3 cells. All experiments were repeated
three times independently. D. Ba/F3 cells were transfected with pcDNA3.1(+), OTUD-6B WT, and OTUD-6B C188S vectors. Thirty-two hours later, cell
extracts were analyzed by immunoblot with anti-HA antibody. GAPDH was used as a loading control.
doi:10.1371/journal.pone.0014514.g003
immunoblotted using anti-OTUD-6B antibody. G3PDH was used as a loading control. E&F. Otud-6b RNA level and protein level in primary mouse B
cells after starvation and stimulation with 10 pM mouse IL-3 for the indicated times (0, 0.5, 1, 2, 3, 4, 8, 16, and 24 hours). G3PDH was used as a
loading control. G&H. Otud-6b RNA level in primary mouse B cells after starvation and two hours stimulation with different concentrations (0, 0.01,
0.1, 1, 10, 100, and 1000 pM) of mouse IL-3. G3PDH was used as a loading control.
doi:10.1371/journal.pone.0014514.g002
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6b mRNA. To investigate which AU-rich elements on the 39-UTR
of Otud-6b mRNA is involved in TTP regulation, we next
constructed a series luciferase reporter with different Otud-6b-
specific 39-UTR regions (1221–2950, 1221–2720, and 2721–2950
of mouse Otud-6b cDNA). As 293T cells have very low
endogenous TTP expression [29], we co-transfected HA-TTP
and those luciferase reporter constructs into 293T cells. Luciferase
expression with Otud-6b 39-UTR (1221–2950) was significantly
inhibited by co-transfection of wild-type TTP in 293T cells, while
TTP Zn-FM (TTP zinc finger mutant), which lacks the ability to
bind to mRNA, had no effect (Figure 5G). These data indicated
that the 39UTR of Otud-6b contributes greatly to the mRNA
stability. Furthermore, truncation of Otud-6b 39-UTR showed
that TTP probably binds to the end of Otud-6b 39-UTR as TTP
could significantly reduce luciferase production with the 39UTR
(2721–2950) and has no effect on luciferase expression with the 39-
UTR (1221–2720) (Figure 5G). These results indicated the AU-
rich sequences in the 39UTR 2721–2950 region may contain the
AU-rich element (ARE), which is responsible for Otud-6b mRNA
instability.
Discussion
In this study, we firstly identified an OTU family member,
Otud-6b, to be a functional deubiquitinating enzyme. After serum
starvation, Otud-6b was induced by cytokines following a rapid
decline in B lymphocytes. The induction of Otud-6b is probably
due to robust response after serum starvation and cytokine
stimulation, which is a less physiological condition. However, the
rapid down-regulation of Otud-6b is probably required to
maintain a normal cell cycle as enforced Otud-6b expression
can cause cell cycle arrest in Ba/F3 cells. What is more, Otud-6b is
not expressed (or not detectable) in Ba/F3 cells continually
growing in 1 ng/ml IL-3 (Figure 1B). Taken together, Otud-6b
probably participates in B lymphocytes cell cycle as a negative
regulator. Although these characteristics of Otud-6b are identified,
there are still many questions need further study.
Cytokine-inducible enhancer and transcription factors
Otud-6b induction-decline expression pattern is similar to those
of mouse DUB/USP17 family member Dub-1 and Dub-2 [5,14],
which have cytokine-inducible enhancer in the promoter regions,
such as AP-1 and ETS TF binding sites [13,30]. Although the
enhancer element of Otud-6b from 21515 bp to 21397 bp of
Otud-6b is structurally different from those of Dub-1, Dub-1a, and
Dub-2a, the functional transcription factor binding sites are very
similar as the conserved ETS binding site is required for Otud-6b
enhancer activity as well (Figure S9). However, a number of
transcription factors could bind to the ETS binding site, and which
ones are required for Otud-6b induction need further investiga-
tion.
Regulation of OTUD-6B mRNA stability
Degradation of mRNA is important in the regulation of gene
expression [31]. MicroRNAs are post-transcriptional regulators
that bind to complementary sequences in the 39UTR of target
mRNAs, usually resulting in mRNA degradation and gene
silencing [25]. Besides microRNAs, short-lived transcripts can
also be controlled through RNA-binding proteins [32], such as
TTP, AUF1, and BRF1, which can bind to the AREs in 39-UTR
of many cytokine and proto-oncogene mRNAs [27]. On the other
hand, HuR, a ubiquitously expressed member of the Hu family,
could stabilize ARE containing transcripts [33]. In this study we
found that TTP could regulate the post-transcriptional level of
Otud-6b mRNA through the 39-UTR and the AU-rich sequences
in the 39-UTR play vital roles in contributing the stability of Otud-
6b mRNA. However, the mechanism of TTP mediated Otud-6b
mRNA degradation is still unclear. TTP has been reported to bind
to varieties of AU-rich sequences in the 39-UTR of short-lived
transcripts, including TNF-alpha [27], GM-CSF [34], and c-fos
[35]. Many of these TTP binding sites are functional AREs with
tandemly repeat copies of the AUUUA motif. Few exceptions
have been reported such as MHC class I, which contains non-AU-
rich element [29]. Although we identified TTP binds to Otud-6b
mRNA and the AU-rich sequences in the 39UTR 2721–2950
region may contain the AU-rich element (ARE), which motifs
(AREs or non-AREs) in the Otud-6b mRNA are responsible for
TTP binding is unclear. Since TTP has some flexibility in its
sequence requirements for binding, future detailed mutagenesis in
the 39-UTR of Otud-6b mRNA, especially the AU-rich sequences
in the 39UTR 2721–2950 regions, would be necessary to define
the precise sequence requirements for TTP binding. On the other
hand, TTP knock-down could not completely block the degrada-
tion of Otud-6b mRNA, other possible mechanisms involved in
Otud-6b mRNA regulation will need further careful examination.
OTUD-6B substrate(s) and cell cycle
Enforced expression of OTUD-6B causes Ba/F3 cell cycle
arrest at G1 phase, while knockdown of Otud-6b showed no effect
(Figure S5). During the G1-S transition, cyclin D type protein is
synthesized in response to mitogenic stimulation and cyclin D-
CDK4 complex can phosphorylate pRb which can induce cyclin E
synthesis. When there is more cyclin E than p27, the excess cyclin
E triggers phosporylation of p27, which is then started to be
degraded [36,37]. We re-checked cell cycle regulators in OTUD-
6B overexpressed Ba/F3 cells and found that p27 level was up-
regulated and cyclin E level was down-regulated (Figure S10),
which correlates with cell cycle progression. However, the effect
on cyclin D2 levels was modest; and how OTUD-6B cause such
down-regulation still need further investigation as cyclin D2 is
unlikely a substrate of OTUD-6B because we also did not observe
any deubiquitinating activity of OTUD-6B on cyclin D2.
Nevertheless, OTUD-6B probably could directly affect either the
synthesis or the degradation process of cyclin D2 as overexpressing
OTUD-6B in Hela cells could also cause cyclin D2 expression
level down-regulation even without affecting cell cycle (Figure
S10). Interestingly, we also did not observe any effect on p27 and
cyclin E in Hela cells overexpressing OTUD-6B. The lack of cell
cycle arresting effect in Hela cells is probably due to deregulated
cell cycle in cancer cell line [38].
Figure 4. Cyclin D2 level is down-regulated with OTUD-6B overexpression. A & B & C. Real-time PCR, RT-PCR, and immunoblot of OTUD-
6B, GAPDH, cyclin D1, cyclin D2, cyclin D3, p21, p27, p15, p16, cdk4, cdk6, cdc2, cyclin E, Rb, and c-Myc genes from total RNA samples and protein
extracts of DOX(2) and DOX(+) Hela cells. Hela cells were provided by the Cell Bank, Shanghai Institute of Biochemistry and Cell Biology, SIBS, CAS.
D&E .Immunoblot of OTUD-6B, cyclin D2, and p27 with gradient concentrations (0, 0.1, 0.5, 1, 2 ug/ml) of DOX stimulation. Quantitation was
performed with Bandscan 5.0 from 3 independent results. F&G .Immunoblot (left panel) for cyclin D1, cyclin D2, and cyclin D3 on Hela and Ba/F3
cells overexpressing pcDNA3.1(+), HA-OTUD-6B WT, and HA-OTUD-6B C188S. Quantitation (right panel) of cyclin D1, cyclin D2, and cyclin D3 on Hela
and Ba/F3 cells was performed with Bandscan 5.0 from three independent results.
doi:10.1371/journal.pone.0014514.g004
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or pathway OTUD-6B regulates to control the level of cyclin D2.
Many pathways have been reported to regulate cyclin D2 level in
different tissues. For example, cyclin D2 is a direct target gene of
Myc [39] and PU.1 transcription factor [40]. Its expression can also
be induced by colony-stimulating factor-1 receptor through Src,
MAPK/ERK kinase, and c-Myc pathways in macrophages [41].
On the other hand, GSK3 beta can suppress cyclin D2 expression
by tumor suppressor PTEN [42]. Due to the complexity of cyclin
D2 signaling pathway, we had not found the direct substrate of
Figure 5. TTP is involved in Otud-6b mRNA rapid degradation after induction. A. The sequence of Otud-6b 39UTR. AUUUA pentamer or
AUUUUA hexamer are underlined. Each rectangle indicates an AU-rich sequence site. The AU-rich sequence with U surrounding it is indicated as a
black rectangle. B. pSUPER Mock, pSUPER siTTP-1 or 2 and HA-TTP vectors co-expressing Ba/F3 cells were seeded at 2610
5 cells per ml. Cell extracts
were immunoblotted with anti-HA antibody. GFP was used as a loading control. C. Otud-6b RNA level in Ba/F3 cells transfected with pSUPER siTTP-
1,2 vectors after starvation and stimulation with 10 pM mouse IL-3 for the indicated times (0, 0.5, 1, 2, 4, 8, 12, 16, and 24 hours). D. Ba/F3 cells were
transfected with pSUPER Mock, pSUPER siTTP-1 or 2 vectors. 24 later, cells were stimulated by 10 pM IL-3 and incubated with 15 ug/ml Act.D for the
time indicated. The qRT-PCR was performed to detect Otud-6b mRNA remaining at each time point. E. Semi-quantitative RT-PCR analysis of Otud-6b
mRNA remaining at each time point after Act.D adding. F. RT-PCR for Otud-6b mRNA in protein-mRNA immunoprecipitation complex. The mRNAs of
Ba/F3 cells transfected with HA-TTP when response to IL-3 was immunoprecipitated with anti-HA and IgG serum. As a control, Input (10%) denoted
that the RNA sample contained Otud-6b mRNA and didn’t contain genomic DNA. G. TTP transfection had little effect on pGL3 control luciferase
expression. Wild-type TTP transfection resulted in a significant decrease in full-length Otud-6b 39-UTR luciferase reporter expression in 293T cells,
while the TTP Zn-FM did not alter Otud-6b 39-UTR-mediated expression. Different region of Otud-6b 39UTR was inserted into downstream of
luciferase coding region. The truncate 39UTR vectors were constructed depending on the AU-rich sequence distribution. 293T cells were provided by
the Cell Bank, Shanghai Institute of Biochemistry and Cell Biology, SIBS, CAS.
doi:10.1371/journal.pone.0014514.g005
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work reported by Mathew E. Sowa et al. used a CompPASS
method in a global proteomic analysis on DUBs, including OTUD-
6B, and their associated protein complexes [43]. However, likely
because ofthecomplexity ofthesubstrate(s)andthetransientnature
of DUB-substrate interaction, they also failed to identify the right
substrate(s) for OTUD-6B. However, further investigations on
identifying OTUD-6B substrates will still be needed to understand
the mechanism of cell cycle regulation by OTUD-6B.
Materials and Methods
Cell Lines and Cell Culture
Ba/F3 cells were cultured in RPMI1640 medium supplemented
with 10% (v/v) FBS (Invitrogen) and 1 ng/ml recombinant mouse
IL-3 (R&D systems) [5]. Recombinant mouse IL-2, IL-3, IL-4, IL-
13, and granulocyte-macrophage colony-stimulating factor (GM-
CSF) were purchased from R&D systems. Before addition of the
cytokines for induction, Ba/F3 cells were cultured without serum
and IL-3 for two hours. Hela cells were cultured in DMEM
medium with 10% FBS. 293T cells were cultured in DMEM
medium supplemented with 10% FBS. Raji cells were cultured in
RPMI-1640 medium supplemented with 10% FBS. Ba/F3 cells
were kindly supplied by prof. Xin yuan Liu (Shanghai Institute of
Biochemistry and Cell Biology, SIBS, CAS). Hela cells, 293T cells,
Raji cells, and CTLL2 cells were provided by the Cell Bank,
Shanghai Institute of Biochemistry and Cell Biology, SIBS, CAS.
Mouse Primary B Cells Isolation and Induction
DynabeadsH Mouse pan B (B220) (Invitrogen) can be used
directly on whole blood samples from six 4-week C57BL/6 mice
according to the manufacturer’s procedures. Mouse B cells can
then be lysed on the beads using DETACH BEAD CD19
(Invitrogen) to detach the cells from the beads. Isolated mouse B
cells will be bead and antibody free and in perfect shape for
downstream IL-3 induction.
OTUD-6B Cloning and Semi-quantitative RT-PCR of
Otud-6b
OTUD-6B cDNA was amplified from the total RNA of Raji
cells by RT-PCR with specific primers. RT-PCR was performed
at 94uC for 1 min, 50uC for 30 s, and 72uC for 3.5 min for a total
of 40 cycles. The amplified cDNA was subcloned into the
pGEMT-easy vector (Promega) and transformed into E.coli DH5a
(Clontech). Total RNA was isolated by using Trizol (Invitrogen).
Semi-quantitative RT-PCR was performed using a pair of specific
primers for Otud-6b or Otud-6a (Table S3)a t9 4 uC for 1 min,
50uC for 30 s, and 72uC for 1 min for a total of 35 cycles. For cell
cycle regulators screens with RT-PCR, OTUD-6B, GAPDH,
cyclin D1, cyclin D2, cyclin D3, p21, p27, p15, p16, cdk4, cdk6,
cdc2, cyclin E, Rb, and c-Myc genes were performed with the
specific primers (Table S1)a t9 4 uC for 1 min, 55uC for 30 s, and
72uC for 30 s for a total of 30 cycles.
Site-directed Mutagenesis
The OTUD-6B (C188S) mutant was generated by using a
QuikChange TM site-directed mutagenesis kit (Stratagene) to
replace Cys188 with Ser according to the manufacturer’s
instructions.
Deubiquitination Assay
The deubiquitination assay has been previously described [5].
In brief, ubiquitin-b-galactosidase fusion protein (Ub-Met-b-gal)
was expressed from a pACYC184-based plasmid in MC1061 cells.
Purified GST, GST-OTUD-6B WT, GST-OTUD-6B C188S,
GST-CYLD WT, and GST-CYLD CS fusion protein was
incubated with Ub-Met-b-gal supernatant at 4uC with rotation
for 4 hours, then the total protein was analyzed by immunoblot
with anti-beta-gal antibodies (Sigma).
Trypan Blue Staining
2610
5 Ba/F3 cells transfected with pcDNA3.1(+), OTUD-6B
WT, and OTUD-6B C188S vectors and collected after different
time (0 hour, 16 hours, 32 hours, and 48 hours), and then washed
with 4uC PBS, and stained with 0.1 ml of 0.4% Trypan Blue for
5 min at room temperature. Then cells were observed and
counted under a microscope.
Cell Cycle Analysis and Apoptosis Assay
Ba/F3 cells were transfected with pcDNA3.1(+), OTUD-6B WT,
and OTUD-6B C188S vectors. Thirty-two hours later, cells were
washed with4uC PBS and fixed with 70% ethanol at 4uC overnight.
Then cells were treated with 200 ml RNase in 37uC water for 30
minutes and stained with propidium iodide (PI, Sigma). Cell cycle
distribution was measured by flow cytometric assay, MODFIT LT
of FACS Calibur (Becton Dickinson). PI-Annexin V assay was
performed according to the manufacturer’s instructions and
analyzed with CELLQUEST PRO (Becton Dickinson).
Tet-on Systems and Cell Cycle Regulators Screen
Doxycycline (DOX, Sigma)-inducible OTUD-6B expressing
Hela cells were prepared as in Ref [44]. In brief, Hela cells stably
transfected with pTet-On (Clontech) HA-OTUD-6B WT were
treated with or without 2.5 mg/ml DOX. Total RNAs from both
DOX (2) and DOX (+) Hela cells were collected and subjected to
real-time PCR (Table S2) by an iCycler iQ thermal cycler system
(Bio-Rad). Cycling parameters for real-time PCR were the same as
mentioned before. Cell extracts were also collected and subjected
for immunoblot with antibodies against OTUD-6B, c-Myc
(Santacruz), GAPDH, cyclin D1, cyclin D2, cyclin D3, p21, p27,
p15, p16, cdk4, cdk6, cdc2, cyclin E, and Rb antibodies (CST).
Act.D Chase Assay for mRNA Stability Measurement
For mRNA stability measurement, Ba/F3 cells were incubated
with 15 mg/ml actinomycinD (Act.D) to inhibit transcription. At the
indicatedtimepointsafterthe additionofAct.D,cellswere harvested
and total RNA was extracted. The expression levels of Otud-6b at
each time points were measured by qRT-PCR and normalized to
the according G3pdh levels. The remaining mRNA was determined
by comparison with the expression level of the Otud-6b at the zero
time point (designated 1) when Act.D was added.
Luciferase Assay
The pcDNA3.1, HA-TTP, HA-TTP Zn-FM constructs were
generated as previously described [29]. The pGL3 luciferase
constructs contain the Otud-6b 39-UTR nucleotides (1221–2950,
1221–2720, and 2721–2950 of mouse Otud-6b cDNA). 293T cells
were transfected with 1 mg of luciferase constructs and 500 ng of
TTP expression constructs or pcDNA 3.1. Cells were lysed 24 h in
100 ml of luciferase lysis buffer (Promega), and 20 ml of each
sample was read in a luminometer according to the manufacturer’s
protocol.
Immunoprecipitation of mRNA-protein Complex
2610
7 Ba/F3 cells transfected with HA-TTP vector were used
for the immunoprecipitation [45]. 24 hours later, Ba/F3 cells were
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to high levels. The cells were then lysed for 10 min on ice in RNA
immunoprecipitation (RIP) buffer [10 mM Tris-HCl at pH 7.6,
1.5 mM MgCl2, 100 mM NaCl, 1 mM DTT, 0.5% Nonidet P-40,
0.5% Triton X-100, 100 U/ml RNase inhibitor (Promega), 10 mL/
mL protease inhibitor cocktails (Sigma)]. The cell lysate was
centrifuged at 12000 g for 15 min at 4uC and the supernatant of the
cytoplamic lysate was collected for RNA IP assay. Protein-RNA
complexes were incubated with 1 ug anti-HA antibody and rotated
for12 hours at 4uC. Preclearedpro-ASepharosebeads (Amersham)
was used to pull-down anti-HA antibody or pre-immune serum by
incubating overnight at 4uC with continuous rotation in RIP buffer.
The beads were pelleted and the supernatant was removed. These
beads and their bound complexes were recovered by centrifugation
and washed six times with RIP buffer. Otud-6b mRNA was
detected with RT-PCR using the specific primers.
Statistical Analysis
Average values were expressed as mean 6 SD. The statistical
significance was assessed by Student’s t test using SPSS 10.0
statistical software or Excel statistics. P,0.05 was considered
statistically significant.
Supplementary information associated experiments
OTUD-6B antibody production, OTUD-6B recombinant
protein, Otud-6b enhancer luciferase plasmids, and Otud-6b
siRNA design were shown in the (Materials and Methods S1).
Supporting Information
Materials and Methods S1 Supplementary experimental
materials and methods.
Found at: doi:10.1371/journal.pone.0014514.s001 (0.04 MB
DOC)
Figure S1 Amino acid alignment of human OTUD-6B and
OTUD-6A, and mouse Otud-6b by CLUSTAL 2.0.12.
Found at: doi:10.1371/journal.pone.0014514.s002 (0.30 MB TIF)
Figure S2 Immunoblot for GST-DUB fusion protein. Purified
GST (lanes 1 and 4), GST-OTUD-6B WT (lane 2), GST-OTUD-
6B C188S (lane 3), GST-CYLD WT (lane 5), and GST-CYLD CS
(lane 6) were analyzed by immunoblot with an anti-GST
monoclonal antibody.
Found at: doi:10.1371/journal.pone.0014514.s003 (0.17 MB TIF)
Figure S3 IL-2 doesn’t induce Otud-6b expression in Ba/F3
cells. A. Otud-6b RNA level in Ba/F3 cells after starvation and
two hours stimulation with different concentrations (0, 0.01, 0.1, 1,
10, 100, and 1000 pM) of mouse IL-2. B. Otud-6b RNA level in
Ba/F3 cells after starvation and stimulation with 10 pM mouse IL-
2 for the indicated times (0, 0.5, 1, 2, 4, 8, and 16 hours).
Found at: doi:10.1371/journal.pone.0014514.s004 (0.13 MB TIF)
Figure S4 Characterization of the rabbit antibody for endogenous
OTUD-6B. A. Purified GST-OTUD-6A, GST-OTUD-6B WT, and
GST-OTUD-6B C188S fusion protein was immunoblotted with anti-
OTUD-6B antibody. Then, membranes were stripped and immuno-
blotted with anti-GST antibody. B. Ba/F3 cells were cultured with IL-
3, then transfected with pcDNA3.1(+), HA-OTUD-6B WT, and HA-
Otud-6b WT vectors. Immunoblot was performed with anti-OTUD-
6 B ,a n t i - H A ,a n da n t i - G A P D Ha n t i b o d i e s .
Found at: doi:10.1371/journal.pone.0014514.s005 (0.24 MB TIF)
Figure S5 Knockdown of Otud-6b has no effect on cell growth.
A&B. Ba/F3 cells were transfected with pSUPER mock, pSUPER
Otud-6b siRNA-1 or 2 vectors, then stimulated with 10pM IL-3
for 2 hours after starvation. Total RNAs were analyzed by RT-
PCR, and cell extracts were immunoblotted with anti-HA
antibody. G3PDH was used as a loading control. C. pSUPER
Mock and pSUPER Otud-6b siRNA-1 or 2 expressing Ba/F3 cells
were seeded at 26105 cells per ml and stimulated by 10 pM IL-3
and then analyzed by trypan blue exclusion assay 16 hours later.
Found at: doi:10.1371/journal.pone.0014514.s006 (0.31 MB TIF)
Figure S6 Knockdown of OTUD-6B has no effect on cyclin D2
level. A. The levels of Cyclin D2 had no difference when OTUD-
6B was knocked down in Hela cells. Hela cells transfected with
pSUPER mock, pSUPER-OTUD-6B siRNA-1 or 2. Twenty four
hours later, cell lysates were collected and then subjected to
immunoblot with anti-OTUD-6B, anti-cyclin D2 antibodies.
GAPDH was used as loading control. B. The levels of Cyclin
D2 had no difference when Otud-6b was knocked down in Ba/F3
cells. Ba/F3 cells were stimulated with 10 pM IL-3 for 2 hours.
Found at: doi:10.1371/journal.pone.0014514.s007 (0.45 MB TIF)
Figure S7 Knockdown of AUF1, BRF1 and Dicer1 has no effect
on Otud-6b mRNA level. A, B, and C. Ba/F3 cells were transfected
with pSUPER mock, pSUPER AUF1, BRF1, and Dicer1 siRNA
vectors. AUF1, BRF1, and Dicer1 mRNAs were analyzed by RT-
PCR. G3PDH was used as a loading control. D and E. Otud-6b
RNA level in Ba/F3 cells transfected with pSUPER AUF1, BRF1,
and Dicer1 siRNA vectors after starvation and stimulation with
10 pM mouse IL-3 for the indicated times (0, 0.5, 1, 2, 4, 8, 12, 16,
and24 hours).F.Ba/F3cellsweretransfectedwith pSUPERMock,
AUF1, BRF1, and Dicer1 siRNA vectors. 24 hours later, cells were
stimulated by 10 pM IL-3 and incubated with 15 ug/ml Act.D for
the time indicated. The qRT-PCR was performed to detect Otud-
6b mRNA remaining at each time point.
Found at: doi:10.1371/journal.pone.0014514.s008 (0.70 MB TIF)
Figure S8 Scrambled vector has no effect on the Otud-6b
mRNA rapid degradation after induction. A. pSUPER Scramble,
pSUPER siTTP-1 or 2 and HA-TTP vectors co-expressing Ba/F3
cells were seeded at 26105 cells per ml. Scrambled siRNA
sequence is 59- GAGGAGCCGACGCTTAATA-39. Cell extracts
were immunoblotted with anti-HA antibody. GFP was used as a
loading control. B. Otud-6b RNA level in Ba/F3 cells transfected
with pSUPER scramble, siTTP-1,2 vectors after starvation and
stimulation with 10 pM mouse IL-3 for the indicated times (0, 0.5,
1, 2, 4, 8, 12, 16, and 24 hours).
Found at: doi:10.1371/journal.pone.0014514.s009 (0.31 MB TIF)
Figure S9 The Otud-6b gene contains a cytokine-inducible
enhancer element. A. Alignment of the cytokine-inducible enhancer
regions of mouse Dub-1a, Dub-1, Dub-2a, and the promoter region
of mouse Otud-6b. The putative enhancer region of mouse Otud-
6b contains one ETS and one GATA TF binding site. Mutation
sites in motifs are indicated with arrows. B. Luciferase activity was
assayed in Ba/F3 cells that were transfected with the indicated
constructs. The cells were starved and then treated with or without
10 pM mouse IL-3 stimulation. Luciferase assays were performed
after 16 hours of treatment. All ratios are from three independent
experiments. P value was calculated by student’s t test.
Found at: doi:10.1371/journal.pone.0014514.s010 (0.41 MB TIF)
Figure S10 P27 and cyclin E levels in Ba/F3 cells and Hela cells
when overexpression of OTUD-6B WT and OTUD-6B CS. A
and B. Immunoblot for p27 and cyclin E on Ba/F3 cells and Hela
cells overexpressing pcDNA3.1(+), HA-OTUD-6B WT, and HA-
OTUD-6B C188S. C. Cell cycle profile of PI-stained Hela cells
when overexpressing pcDNA3.1(+), HA-OTUD-6B WT, and HA-
OTUD-6B C188S.
Found at: doi:10.1371/journal.pone.0014514.s011 (0.51 MB TIF)
OTUD-6B in Cell Proliferation
PLoS ONE | www.plosone.org 10 January 2011 | Volume 6 | Issue 1 | e14514Table S1 Primers used for RT-PCR in cell cycle regulators
screen.
Found at: doi:10.1371/journal.pone.0014514.s012 (0.04 MB
DOC)
Table S2 Primers used for real time PCR in cell cycle regulators
screen.
Found at: doi:10.1371/journal.pone.0014514.s013 (0.04 MB
DOC)
Table S3 Subcloning primers used in this study.
Found at: doi:10.1371/journal.pone.0014514.s014 (0.05 MB
DOC)
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